Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0390
+0.0020 (5.41%)
Aug 21, 2026, 4:10 PM AEST
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 63.64 million as of August 21, 2026. Its market cap has increased by 33.97% in one year.
Market Cap
63.64M
Enterprise Value
57.88M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 63.64M, an increase of 67.20%. That is a compound annual growth rate of 25.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 63.64M | 23.65% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 90.89M |
| Prescient Therapeutics | 83.07M |
| Arovella Therapeutics | 76.15M |
| Immutep | 75.16M |
| Amplia Therapeutics | 74.43M |
| Avecho Biotechnology | 73.41M |
| Botanix Pharmaceuticals | 54.69M |
| Radiopharm Theranostics | 52.05M |